Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

If there's one thing blue-state liberals and Trump populists can agree on, it's that pharmaceutical firms charge too much for their drugs. That core belief has propelled Connecticut to the leading ...